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Abstract (word count 196)  
Accurate identification of ischaemic penumbra will improve stroke patient selection 
for reperfusion therapies and clinical trials. Current MRI techniques have limitations 
and lack validation. Oxygen challenge T2* MRI (T2*OC) uses oxygen as a biotracer 
to detect tissue metabolism, with penumbra displaying the greatest T2* signal change 
during OC.  [14C]2-deoxyglucose autoradiography was combined with T2* OC to  
determine  metabolic status of T2*-defined  penumbra.   
Permanent middle cerebral artery occlusion was induced in anaesthetised male 
Sprague Dawley rats (n=6). Ischaemic injury and perfusion deficit were determined 
by diffusion- and perfusion-weighted imaging, respectively. At 147±32 minutes post-
stroke, T2*-signal change was measured during a 5 minute 100% oxygen challenge, 
immediately following by 125 μCi/kg [14C]2-deoxyglucose, i.v.. MRI images were 
co-registered with corresponding autoradiograms.  
Regions of interest were located within ischaemic core, T2*-defined penumbra, 
equivalent contralateral structures and a region of hyperglycolysis.  
A T2* signal increase of 9.22±3.9% (mean±SD) was recorded in presumed penumbra 
which displayed LCMRglu values equivalent to contralateral cortex. T2* signal 
change was negligible in ischaemic core, 3.2±0.78% in contralateral regions and 
1.41±0.62% in hyperglycolytic tissue, located outside OC-defined penumbra and 
within the diffusion abnormality. The results support the utility of OC-MRI to detect 
viable penumbral tissue following stroke.  
 
Running Headline: Detecting penumbra using T2* MRI and O2 challenge 
Key words: ADC, CBF, imaging, LCMRglu, MCAO, rat  
Abbreviations: ADCav= Apparent diffusion coefficient; CMRO2 = cerebral metabolic 
rate of oxygen; DWI = diffusion-weighted imaging; DWI/PWI mismatch = 
diffusion/perfusion mismatch; MCAO = middle cerebral artery occlusion; OC = 
oxygen challenge; PaO2 = Partial Pressure of Oxygen in Arterial Blood; PaCO2 = 
Partial Pressure of Oxygen in Arterial Blood; PWI = perfusion-weighted imaging; 
ROI = region of interest; [14C]2-DG = [14C]-2-deoxyglucose.  
Word count (excluding references, tables and figure legends): 4218   
 
Introduction 
 
Stroke is a leading cause of morbidity and the second most common cause of 
mortality worldwide (Donnan et al, 2008). Disability and mortality are reduced by 
admission to specialised stroke units, but the only widely approved drug treatment for 
acute cerebral ischaemia is recombinant tissue plasminogen activator (rt-PA), for 
which many patients are ineligible. Low treatment rates with i.v. rt-PA (for example 
1-7% in the USA following FDA approval (Wardlaw et al, 2009)) partly reflect delay 
in presentation and institutional barriers to rapid medical assessment (Katzan et al, 
2004; Kahn et al, 2005), but also that clinical uncertainty prevents treatment in many 
circumstances. Such clinical uncertainty includes patients awaking with symptoms in 
whom onset time is unclear, rapidly improving or mild symptoms, and perceived 
concern about bleeding risks (Barber et al., 2001). Failure to identify efficacy in both 
thrombolysis and neuroprotection trials (Kidwell et al, 2001) could have arisen from 
treatment being administered at a time point when no salvageable (penumbral) tissue 
remained, but potentially also from recruitment of patients lacking target penumbral 
tissue even within conventional time windows (Muir, 2002). The possible 
improvement in safety with more advanced penumbral imaging selection for 
thrombolysis has also been suggested (Schellinger 2003).  
 
MRI-based diffusion/perfusion (DWI/PWI) mismatch provides an indirect index of 
the ischaemic penumbra.   When used to select patients for thrombolysis, it identified 
patterns that may define treatment responsiveness (DEFUSE study, Albers, Thijs & 
Wechsler et al., 2006) and has been used to select patients for an extended time 
window (Hacke, 2005).  However, the technique has not been validated clinically and 
has a number of limitations.  No DWI or apparent diffusion coefficient (ADC) 
threshold has been determined which can differentiate between irreversibly damaged 
and potentially recoverable tissue (Guadagno et al, 2004) and when thresholds are 
applied, the lesions identified can be fully or partially reversed by reperfusion in 
animal models and man (Kidwell et al, 2000).  Defining a threshold for the perfusion 
deficit is equally difficult and may include benign oligaemic tissue which is not at risk 
(Butcher et al, 2005).    
 
We have developed an alternative technique that identifies the penumbra based on its 
metabolic status which could represent significant improvements on current 
penumbral imaging. Oxygen challenge (OC) MRI uses a transient hyperoxic 
challenge to identify changes in the deoxyhaemoglobin:oxyhaemoglobin ratio, 
detected by T2*-weighted MRI (Santosh et al, 2008, Dani et al., 2010). Paramagnetic 
deoxyhaemoglobin and free oxygen in the plasma reduce T2* signal, whilst 
diamagnetic oxyhaemoglobin has a minimal influence on T2* (Uematsu et al, 2007). 
Following stroke, penumbral oxidative metabolism (CMRO2) is maintained in the 
face of reduced cerebral perfusion pressure by increasing oxygen extraction fraction 
(OEF) (Powers, 1991). This increases the deoxy:oxyhaemoglobin ratio in the 
vasculature resulting in a decreased T2* signal within penumbra. Increased oxygen 
delivery during oxygen challenge will convert deoxyhaemoglobin back to 
oxyhaemoglobin with a resultant increase in T2* signal, the magnitude of which 
should be greatest in regions with greatest OEF. T2* maps can be generated that locate 
and quantify the percentage change in T2* signal throughout the territory of the 
occluded artery. In addition, the maintenance of this increased signal during the 
oxygen challenge and its return back to baseline following OC is consistent with T2* 
signal change indicating oxygen consumption. This technique may therefore yield 
information on oxygen metabolism that more closely correlates with positron 
emission tomography (PET) definitions of the penumbra. 
 
In our previous study (Santosh et al., 2008), the OC technique applied to a rodent 
middle cerebral artery occlusion model (MCAO) defined an inner boundary between 
metabolically inactive ischaemic core (no T2* signal increase to OC) and 
metabolically active penumbra (T2* signal increase to OC) which overlapped 
approximately with DWI/PWI mismatch, and correlated with histological appearances 
of neuronal integrity.  The greater magnitude of T2* signal increase in penumbra 
during OC compared to normal cortex may differentiate between hypoperfused 
penumbra and benign oligaemic tissue on the basis of differences in CMRO2, thereby 
providing a means of defining the outer boundary of the penumbra.    
 
The aim of this study was to provide further validation for the T2* OC MRI technique: 
firstly to confirm viability of tissue within regions defined as penumbra using OC. 
This was achieved by co-registering T2* OC maps with corresponding [14C]2-
deoxyglucose (2-DG) autoradiograms, which provide information on local cerebral 
glucose utilisation (LCMRglu) as a quantitative representation of metabolic activity. 
Secondly, regions of interest (ROIs) identified on 2-DG autoradiograms and MRI 
scans were investigated to determine the LCMRglu and MRI signatures of different 
tissue compartments in the ischaemic hemisphere.   
 
Materials and Methods 
Rodent MCAO surgery 
Experiments were performed under license from the UK Home Office and were 
subject to the Animals (Scientific Procedures) Act, 1986. Male Sprague Dawley rats 
(289±13g, n=6, Harlan, Bicester, UK), fasted overnight, were initially anaesthetised 
with 5% inhaled isofluorane in an induction chamber at room temperature. Following 
a surgical tracheotomy, animals were artificially ventilated with 2% isofluorane 
delivered in air, slightly enriched with oxygen (30%) to maintain physiological 
stability throughout the experiment. Blood gases were sampled at baseline in the 5 
min before the start of OC, and half way through 100% O2 inhalation, and maintained 
within the normal physiological range apart from increased arterial partial pressure of 
oxygen (PaO2) during the oxygen challenge. PaCO2 was maintained between 35 - 45 
mm Hg to minimise cerebrovascular reactivity (Table 1). A rectal thermocouple 
provided continual monitoring of core body temperature which was maintained at 
37±0.5oC. 
 
Polyethylene catheters (Portex: external diameter 0.96 mm; internal diameter 0.58 
mm; 70 cm long) were placed in both femoral arteries, to continuously monitor blood 
pressure and conduct blood gas analysis, and a femoral vein for [14C]2-deoxyglucose 
administration. Middle cerebral artery occlusion (MCAO) was achieved by the 
intraluminal filament technique (Longa et al., 1989), where a 3-0 nylon monofilament 
with a bulbed tip was introduced through the internal carotid artery and advanced to 
block the origin of the middle cerebral artery.   
 
MRI Scanning   
Magnetic resonance imaging data were acquired on a Bruker Biospec 7T/30 cm 
system equipped with an inserted gradient coil (121 mm ID, 400mT/m) and a 72 mm 
birdcage resonator. After stroke surgery, animals were placed prone in a rat cradle, 
with the head restrained using ear and tooth bars to limit movement, and a linear 
surface receiver coil (2 cm diameter) placed above the head of the animal. 
 
T2 scanning 
A RARE T2 sequence (effective TE: 46.8 ms, TR: 5000s; in plane resolution of 97µm; 
30 slices of 0.5mm thickness) provided the neuroanatomical template for co-
registration of T2* scans with DWI and PWI scans and 2-DG autoradiograms (Figure 
1A & B).  
 
T2* scanning  
The sequence used to measure T2* changes during OC was a single shot, gradient 
echo (EPI) sequence. (TE: 20ms, TR: 10s,matrix 96 x 96, FOV 25 x25 mm2, 8 
contiguous slices of 1.5mm thickness, 2 averages, temporal resolution 20s, 75 
repetitions). Two coronal MRI slices which corresponded to territory supplied by the 
middle cerebral artery were selected for analysis.  The paradigm for the T2* weighted 
oxygen challenge sequence was 5 minutes breathing air, followed by 5 minutes 
breathing 100% oxygen, and then 15 minutes breathing air. 
 
DWI scanning 
DWI was performed to identify ischaemically injured tissue (Spin Echo planar (EPI) 
TE: 43 ms, TR: 4000.3 ms, in plane resolution of 260 um, 3 directions: x, y, z, B 
values: 0, 1000 s/mm2, 8 slices of 1.5mm thickness).  
 
Arterial Spin Labelling (ASL) 
Non-invasive quantitative CBF was carried out on 2 coronal slices within the MCA 
territory using a form of pseudo-continuous ASL based on a train of adiabatic 
inversion pulses (Moffat et al, 2005). The sequence employs a spin-echo echo-planar-
imaging (EPI) imaging module (TE 20ms, TR 7000ms, matrix 96 x 96, FOV 25 x 25 
mm2, slice thickness 1.5mm, 16 averages, 4 shots) preceded by 50 hyperbolic secant 
inversion pulses in a 3s train.  
 
 [14C] 2-Deoxyglucose autoradiography 
At the end of the MRI scanning session, animals were quickly removed from the 
magnet, and a bolus of [14C]2-deoxyglucose injected intravenously at a steady rate 
over 30 seconds (125 µCi/kg in 0.6 ml heparinised saline, Perkin-Elmer). Plasma 
glucose and 14C were analysed from fourteen timed arterial blood samples over 45 
minutes by glucose oxidase assay and liquid scintillation analysis, respectively. At 45 
minutes, animals were rapidly killed by intravenous injection of sodium 
pentobarbitone and the brains quickly dissected out, frozen (isopentane, -40oC) and 
processed for quantitative autoradiography. Coronal cryostat sections (20µm) were 
exposed to X-ray film (Kodak Biomax MR film) for 3 days with a set of 14C standards 
(Amersham Biosciences, GE Healthcare). Autoradiograms were analysed using a 
computer digitised image analysis system (MCID v4, Interfocus). 
Quantitative optical density measurements were taken from 5 regions of interest 
(ROIs, defined in detail below and shown in Figure 2): 1. ischaemic core; 2. 
penumbra; 3. an intermediate region of increased glucose utilisation at the boundary 
of the ischaemic core (see Figure 2C); 4. & 5. contralateral regions homotopic to the 
penumbra and ischaemic core, respectively. Optical density values were converted 
into 14C tissue concentrations using the calibration curve derived from the set of 14C 
standards. The 14C tissue concentrations along with the plasma glucose and 14C 
plasma concentrations were used to calculate LCMRglu (µmol/100g/min) in ROIs 
using the operational equation of Sokoloff et al (1977). 
Glucose utilisation for each ROI was generated from ten autoradiographic images 
covering the rostro-caudal extent of each MRI slice (1.5mm) to accurately equate T2* 
signal change maps with glucose utilisation.  
 
Defining the ischaemic penumbra with T2* OC 
The time course and size of the T2* signal change was analysed within ROIs (see 
Figure 3). T2* percentage signal change was calculated from time course graphs, 
where the average baseline signal was subtracted from the peak signal during oxygen 
challenge. This value was then divided by the average baseline signal and multiplied 
by 100.  T2*OC percentage signal change maps were generated using Image J 
software (http://rsb.info.nih.gov/ij/) 
Penumbral tissue was defined using a threshold based on the empirical rule: the mean 
plus 2 Standard Deviations (SD) of the T2* value of the contralateral hemisphere, 
excluding the ventricles (see Figure 2B).  
 
Defining the ischaemic penumbra with DWI/PWI mismatch  
DWI and PWI (using ASL) were used to define mismatch prior to the T2*OC protocol 
and data analysed on two selected coronal slices within the MCA territory (Figure 1).  
Quantitative ADCav maps, in units of square millimetres per second, were calculated 
using the Stejskal-Tanner equation (Stejskal and Tanner, 1965). ADC maps and CBF 
maps were generated using Image J software.  A 16.5% reduction of mean 
contralateral ADC was used to determine ischaemic lesion volume, which has been 
shown to match closely the final infarct size following permanent MCAO in Sprague 
Dawley rats (Lo et al, 1997).  PWI was carried out on the 5th and 6th coronal slices 
within core MCA territory and the perfusion deficit area was calculated based on a 
57% reduction of mean contralateral CBF (Meng et al., 2004).  ADC and CBF maps 
were overlaid to identify the DWI/PWI mismatch area defined as the difference 
between the perfusion deficit and the ADC lesion area on the corresponding slice. For 
analysis, the data for the rostral and caudal slices were combined. 
 
Volumetric analysis of penumbra, hypo- and hyperglycaemia  
Volumetric analysis of penumbra (in terms of mismatch and the T2*OC), ADC 
defined lesion, perfusion deficit and hypo- and hyperglycaemic tissue on 2-
deoxyglucose autoradiograms were performed and data expressed as the mean volume 
within the MCA territory included in the ASL scans. For 2-deoxyglucose  
autoradiograms, images were analysed to cover the same rostro-caudal extent as the 
MR images, and were thresholded to determine the region of severely reduced glucose 
use (glucose values below 10  µmol/100g/min) and the hyperglycolytic band (tissue 
with glucose values above 60 µmol/100g/min). 
 
Regions of Interest    
Circular ROIs were selected according to specific features on the images (Figure 2), 
and to ensure placement solely within the areas of interest and uniformity in ROI size, 
ROIs were chosen manually (spanning 80 pixels). The researcher responsible for ROI 
placement was blinded to the autoradiograph data during MRI ROI placement and 
vice versa. MRI-based ROIs were defined and placed within 1. Ischaemic core in 
caudate nucleus within the thresholded ADC lesion (Figure 2E, red) and, 2. Its mirror 
contralateral region (sky blue), manually designated by researcher; 3. Penumbra as 
defined by thresholded T2* percentage signal change (Figure 2B, green); 4. 
Equivalent contralateral cortex (white), and, 5. A cortical hyperglycolytic region 
selected from the 2-DG autoradiogram (Figure 2C, yellow).  
 
Co-registration and Regions of Interest Analysis 
The processed data from the T2*OC, 2-DG, thresholded ADC and CBF maps, were 
co-registered to: a) generate ROI data, and b) identify the location of the DWI/PWI 
mismatch (Figure 1C and D). Linear co-registration was first carried out using 
Analyze and then DWI, ASL, T2*- and 2-DG images were warped to their 
corresponding RARE T2 slices using AIR 5.2.6 (Automated Image Registration).  
 
Statistical analysis 
All data are presented as mean±SD. Data were normally distributed, and as such, 
physiological variables at baseline (pre-OC) and during OC were analysed by 
Student’s paired t-test. T2* signal, ADC, CBF and LCMRglu values in different ROIs 
were analysed by one-way analysis of variance followed by Student’s paired t-test 
with a Bonferroni correction for multiple comparisons. A paired t-test was used to 
analyse the temporal evolution of the ADC-derived lesion volume. All data were 
tested to confirm normal distribution using the D’Agostino and Pearson normality 
test.  
 
Results 
 
Physiological variables  
Mean time to commence OC was 147±32min after MCAO. Physiological variables 
were recorded immediately before and during OC (Table 1). PaO2 increased 
significantly (262%, p<0.0001) as expected during OC, PaCO2 did not change and 
MABP increased significantly (11%, p<0.05). The mean plasma glucose prior to 
scanning was 9.8±2.7 mmol/l.  
 
T2* percentage signal change to OC  
T2* percentage signal change during OC was measured over two coronal slices.  
Thresholded T2* maps revealed a region of increased signal which corresponded 
approximately with the DWI/PWI mismatch (Figure 2B&F).  Examining the 
individual T2* time course data, (Figure 3) T2* signal increase in this penumbral ROI 
was 9.2±3.9%, significantly greater than in the contralateral ROI (2.76±0.3%, 
p<0.001, Figure 4). In ischaemic core, mean T2* signal during OC was reduced (-
0.49±1.6%) compared to the contralateral caudate nucleus ROI (3.56±0.94%, p<0.01). 
In the hyperglycolytic ROI, there was a small T2* signal increase of 1.4±0.6% which 
had a significantly smaller signal response than the contralateral cortex (p<0.05) and 
penumbral ROI (p<0.001).  
 
Glucose use values in ROIs 
[14C]2-deoxyglucose autoradiography confirmed glucose use within the T2*OC -
defined penumbra, which was not significantly different from the contralateral ROI 
(22.67±2.1µmol/100g/min compared to 20.1±2.3 µmol/100g/min, Figure 5).  Glucose 
use was below the limit of detection in ischaemic core (Figure 2C& 5) and was 
markedly increased in the hyperglycolytic ROI (79.7±12 µmol/100g/min, compared 
to contralateral cortex 20.1±2.3 µmol/100g/min, p<0.001). The hyperglycolytic ROI 
(279% increase in LCMRglu) occurred within the boundary of the ADC lesion. It 
displayed a small increase in T2*signal to OC which was significantly smaller 
(p<0.05) than the T2* increase in contralateral cortex (Figure 4). 
 
Absolute glucose utilisation values were low compared to most values from the 
literature, which are generated from conscious animals. In order to confirm the 
validity of our 2-DG technique, in an additional animal, anaesthesia was withdrawn 
following MRI scanning and [14C]2-deoxyglucose autoradiography carried out 2 
hours later when the animal was fully conscious. Glucose use values were similar to 
reported values, and proportionally higher in each ROI, when compared to 
anaesthetised animals: contralateral cortex 41.67 µmol/100g/min; contralateral 
caudate nucleus 46.7 µmol/100g/min; penumbra, 69 µmol/100g/min (62% increase);  
hyperglycolytic ROI, 91 µmol/100g/min (122% increase); ischaemic core, 1.43 
µmol/100g/min (97% decrease relative to contralateral caudate nucleus). Therefore, 
the low glucose utilisation values in the MRI study were most likely due to the level 
and duration of anaesthesia (See Supplementary Material). 
To dismiss the possibility that the presence of the hyperglycolytic band may be a 
confound of O2 administration, an additional rat underwent MCAO, and when fully 
conscious [14C]2-deoxyglucose autoradiography was carried out without OC. The 
hyperglycolytic band was present, suggesting the OC per se was not responsible for 
generating hyperglycolytic tissue.   
 
Severity of ischaemia and tissue viability 
On quantitative CBF maps (Figure 2D), contralateral cortex and caudate nucleus ROIs 
had mean CBF values of 185±45 and 165±31 mL/100g/min, respectively. CBF within 
ischaemic core, hyperglycolytic and penumbra ROIs was significantly reduced 
(7.9±4.7, 21±0.2, and 37±66 mL/100g/min, respectively, all p<0.001) relative to the 
equivalent contralateral ROI (Figure 6A).  
On ADC maps (Figure 2E) ROIs in contralateral cortex and caudate nucleus had a 
mean ADC of 0.73±0.06 and 0.74±0.02 x10-3 mm2/sec, respectively (Figure 6B). 
ADC values were significantly reduced in ischaemic core and hyperglycolytic ROIs 
(0.47±0.04 and 0.51±0.08 x10-3 mm2/sec, respectively p<0.001) while in the T2* OC -
defined penumbral ROI, mean ADC value (0.71±0.04x10-3 mm2/sec) was not 
significantly reduced compared to contralateral cortex (p>0.05, Figure 6B). 
 
Penumbra defined by DWI/PWI mismatch 
For comparison, penumbra, as defined by DWI/PWI mismatch was mapped over two 
coronal slices from the co-registered ADC and ASL scans (Figure 1C & D, 2F).  
 
Evolution of ADC-derived lesion volume 
DWI scans generated at the start and conclusion of the MRI scanning session 
provided information on the evolution of ischaemic injury over time. A significant 
increase in the ADC-derived lesion volume (106±66mm3 at 52±11 minutes compared 
to 185±130mm3 at 106±8 minutes post-stroke, p<0.05) highlighted the progression of 
damage in the acute stroke period and the concomitant loss of penumbral tissue.  
 
Volumetric analysis of penumbra, hypo- and hyperglycaemia  
The volume of perfusion deficit determined at 76.4±13.2 min post-stroke, was 
103.1±21 mm3, the ADC lesion volume, determined at 106±8 min post-stroke was 
80.7±30 mm3, generating a DWI/PWI mismatch volume of 22.3±19 mm3. The 
thresholded T2*OC-defined penumbra, determined at 147±32min, was 15±9 mm3. 
Mismatch- and T2*OC-defined penumbral volumes were approximately 28% and 
19% of the volume of the ADC-defined ischaemic core, respectively.  The volume of 
severely reduced glucose use in ischaemic core was 52.8±18 mm3 and the volume of 
the hyperglycolytic band was 21.1±16 mm3 (total volume incorporating the region of 
severely reduced glucose use and the hyperglycolytic band was 73.9±26 mm3).   
 
Discussion   
 
We previously described the oxygen challenge MRI technique in a focal cerebral 
ischaemia model and compared it with DWI/PWI mismatch and histologically-
defined neuronal morphology (Santosh et al., 2008). We have also demonstrated 
feasibility of the technique in clinical use in acute stroke (Dani et al, 2010). The 
current study provides evidence of ongoing metabolism in T2*OC -defined penumbra 
and provides more direct validation for the technique. In addition, co-registration of 
[14C]2-deoxyglucose autoradiography with MRI has provided detailed information on 
the adjacent tissue compartments within the ischaemic hemisphere which demonstrate 
markedly different levels of glucose metabolism. We propose that the T2*OC 
technique indirectly identifies penumbra from its higher oxygen extraction fraction 
and how this influences deoxy/oxyhaemoglobin ratios and T2* signal. However, we 
acknowledge that other factors may give rise to an increase in T2* signal in the 
penumbra. For example, an increased cerebral blood volume in penumbral tissue may 
increase deoxyhaemoglobin in this region, thus magnifying the T2* response. 
 
MRI-defined DWI-PWI mismatch identifies penumbra in a similar, but not exact 
neuroanatomical location (Figure 2). However, the underlying assumptions are 
undermined by reversibility of the DWI lesion with reperfusion, uncertainty over 
relevant perfusion thresholds, and the variable metabolic state of DWI lesion voxels. 
Information on metabolic state should improve penumbral definition. BOLD MRI 
offers information on oxygen consumption and delivery (Baird & Warach, 1999; 
Kavec et al, 2001), but static T2*-weighted MRI under normoxic conditions has not 
adequately delineated penumbra in ischaemic stroke patients (Tamura et al, 2002; 
Grohn & Kauppinen, 2001), possibly because deoxyhaemoglobin is not rapidly 
cleared in ischaemic conditions (Giesler, et al, 2006). We hypothesised that mapping 
dynamic changes in T2* in response to oxygen challenge should improve 
discrimination between penumbra and surrounding tissue compartments (Santosh et 
al, 2008).   
 
Our results demonstrate a region of significant T2* increase during OC localised to a 
cortical boundary zone between the MCA and anterior cerebral artery territories 
which overlapped the DWI/PWI mismatch area.  This region displayed metabolism 
not significantly different from contralateral normal tissue, and significantly greater 
than infarct core which is consistent with previous [14C]2-deoxyglucose studies in 
acute focal ischaemia (Belayev et al, 1997; Tohyama et al, 1998).  
 
A smaller T2* signal increase to OC, compared to penumbral tissue, would also be 
expected in normal metabolising tissue (as shown in Santosh et al., 2008) and in all 
six animals, the hemisphere contralateral to MCAO showed measureable increases in 
T2* signal intensity during OC (Figure 3&4). By co-registering thresholded T2* maps 
with glucose use autoradiograms, a metabolic signature of normal tissue was 
generated to allow comparison with the ischaemic hemisphere. Our MR findings were 
consistent with the previous study (Santosh et al, 2008), in which the ischaemic core, 
defined by DWI, was notable as a region with negligible T2* signal change. It 
registered undetectable glucose use values, thus confirming metabolic inactivity in 
this tissue compartment where CMRO2 and OEF would be expected to be markedly 
reduced or absent.  
 
An intermediate tissue compartment, identified as hyperglycolytic on autoradiograms, 
displayed a small (sub-threshold) T2* signal change and lay inside the boundary of the 
ADC abnormality (Figures 2, 3 & 5). This may point to residual oxygen utilisation on 
the border of the ADC abnormality (Figure 4), in tissue with ADC and CBF values 
intermediate between the ischaemic core and T2*-defined penumbra (6A & B). The 
presence of hyperglycolysis within the ADC lesion suggests the tissue is still 
metabolically active, and may not be irreversibly injured at this time point. This 
region may therefore be critically injured and employing anaerobic glycolysis 
(Nedergaard and Astrup, 1986) which cannot sustain viability. Since some oxygen is 
being extracted from the blood, this suggests some oxidative metabolism persists but 
may indicate tissue destined for rapid, irreversible damage. This supports recent 
BOLD MR studies that propose the ADC lesion may not only incorporate tissue that 
is destined to die, but also severely injured, still viable tissue (Kidwell et al, 2002). A 
number of studies have reported reversibility of the ADC lesion following reperfusion 
(Mintorovitch et al, 1991; Minematsu et al, 1992: Kidwell et al, 2000).  
Hypermetabolic tissue displaying a small T2* % signal change may therefore indicate 
an intermediate compartment of the ischaemic penumbra situated within both the 
ADC abnormality and the perfusion deficit, whose fate may be being determined by 
secondary insults post-stroke, such as pre-terminal spreading depolarisations which 
may exhaust ATP levels in vulnerable cells.  
 
Limitations of the DWI/PWI mismatch technique  
Despite its limitations, the DWI/PWI mismatch model provides information on 
location and severity of ischaemia (derived from perfusion-weighted imaging, PWI), 
tissue viability status (apparent diffusion coefficient, ADC values derived from 
diffusion-weighted imaging, DWI), and therefore approximate location and size of 
penumbra. PWI and DWI scans were therefore included in the scanning routine for 
comparison with T2*OC identification of penumbra. A number of studies have shown 
that differentiation between viable and non-viable tissue is difficult, using the 
diffusion abnormality (Kidwell et al, 2000; Fiehler et al, 2002) which correlates 
poorly with final infarct (Li et al, 1999). As mentioned above, DWI lesions may be 
recoverable following prompt reperfusion in animal models and man, and may not be 
destined for infarction (Schlaug et al, 1997; Mintorovitch et al, 1991; Kidwell et al, 
2000). Additionally, the perfusion deficit may incorporate tissue with benign 
oligaemia (destined to survive) even when optimal MRI thresholds (themselves as yet 
incompletely defined) are applied (Butcher et al, 2005). As such, the inner and outer 
margins of the penumbra may not be adequately delineated using the mismatch 
technique which has been shown to frequently overestimate the final lesion size 
(Kucinski et al, 2005) 
 
Limitations 
The [14C] 2-DG method may not accurately define LCMRglu because the increase in 
radioactivity registered may either be a result of real glucose consumption or a 
methodological artifact from an increase in the lumped constant. In normal conditions, 
the lumped constant in the 2DG technique is stable over a large spectrum of plasma 
glucose concentrations (Sokoloff et al, 1977). With reduced glucose supply – such as 
during ischaemia - the lumped constant may increase considerably (Suda et al, 1990; 
Vannucci et al, 1989; Gilland and Hagberg, 1996). As there is reduced glucose 
availability, the glucose distribution volume decreases and the lumped constant 
increases because 2-DG is the preferred sugar for phosphorylation by hexokinase. As 
such, local values of the lumped constant should be estimated, which may be derived 
by measuring the brain uptake of methlyglucose (Dienel et al, 1991, Gjedde et al, 
1985). Another limitation is the lack of a gold standard or independent identification 
method for penumbra to compare T2*OC with.  
 
Summary 
 
The T2*OC technique represents a clinically-translatable method of yielding 
metabolic information from the ischaemic brain that may improve delineation of 
penumbral tissue after acute ischaemic stroke. By exploiting the different magnetic 
properties of oxy- and deoxyhaemoglobin, the dynamic response to oxygen 
administration may detect tissue capacity for oxygen utilisation and define the 
ischaemic penumbra on the basis of oxygen extraction and metabolism. This study 
therefore supports the utility of the oxygen challenge technique to provide information 
on oxygen metabolism and tissue viability following stroke.  
 
Supplementary information is available at the Journal of Cerebral Blood Flow & 
Metabolism website - www.nature.com/jcbfm 
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Table 1 
 
 
                       PHYSIOLOGICAL DATA (n = 6) 
                                            BASELINE   DURING OC 
    MABP   82.4 ± 7     91.4 ± 6.7* 
    PaCO2 (mmHg)   34.8 ± 7     36.3 ± 8.5 
    PaO2 (mmHg)   85.8 ± 7.4   310.6 ± 84.1** 
    BLOOD pH   7.32 ± 0.04     7.32 ± 0.04 
 
 
 
 
 
 
 
 
 
 
 
Titles and Legends to Figures 
 
Table 1: Physiological variables at baseline and during oxygen challenge. Data 
expressed as mean±SD, * p<0.05 and ** p<0.0001, Student’s paired t-test.  
 
Figure 1: RARE T2 neuroanatomical templates for caudal (A) and rostral (B) middle 
cerebral artery territory slices of interest. Corresponding coregistered PWI and DWI 
threshold images displaying DWI lesion (white) superimposed on Perfusion deficit 
(red) revealing   DWI/PWI mismatch areas for caudal  (C) and rostral (D) slices.  
 
Figure 2: Representative MRI maps and 2-DG autoradiograms from the rostral slice 
in a stroke rat.  A) T2* OC % signal change map, B) Thresholded T2* OC map, C) 
[14C] 2-deoxyglucose (2-DG) autoradiogram, D) CBF map (mL/100g/min), E) ADC 
map (x10-3 mm2/sec), and F) DWI/PWI overlay (mismatch tissue shown in red).   
ROIs were defined as follows 
Green ROI: Penumbra – the thresholded region displaying the greatest T2* percentage 
signal change excluding veins and ventricles (B).  
Yellow ROI: Hyperglycolytic region – identified by the dark band within the 
ipsilateral cortex on the [14C]2-deoxyglucose autoradiogram (C). 
Red ROI: Ischaemic core – within the ADC-derived lesion in the caudate nucleus  
White ROI: Contralateral cortex – homotopic to the penumbra ROI 
Sky Blue ROI: Contralateral caudate nucleus – homotopic to the ischaemic core ROI 
 
Figure 3: EPI T2* OC signal time course:  Time course T2* signal change during OC 
in: ADC-derived ischaemic core (Red); Cortical hyperglycolytic region from 2-
deoxyglucose autoradiogram (Yellow); a region corresponding to the greatest T2*% 
signal change increase adjacent to hyperglycolytic band (Green); corresponding 
regions on:    the contralateral cortex (Black) and caudate nucleus (Sky Blue). Each 
line represents data from a single animal. Within each animal, all data were 
normalized to the average signal over the 5 mins prior to OC. Blue box represents 
period of 100% oxygen inhalation. 
 
Figure 4: T2* percentage signal change from baseline in ROIs. Individual animal data 
with horizontal lines representing means. ***, p<0.001 and *, p<0.05 relative to 
contralateral cortex ROI. ##, p<0.01 relative to contralateral caudate nucleus 
 ##, p<0.01 compared to contralateral caudate nucleus  
 
Figure 5:  LCMRglu in ROIs. Individual animal data with horizontal lines 
representing means. ***, p<0.001 relative to contralateral cortex. ###, p<0.001 
relative to contralateral caudate nucleus. 
 
Figure 6: CBF (A) and ADC (B) in ROIs.  Individual animal data with horizontal 
lines representing means. ***, ### (p<0.001) relative to contralateral cortex and 
contralateral caudate nucleus, respectively. 
 
 
